Academic radiation oncology: research profile
The aim of Academic Radiation Oncology (ADRO) is to innovate technological and biological advances in radiotherapy, radiobiology and molecular imaging for translation into clinical practice, leading to improved tumour control with a concomitant reduction in side-effects.
Research groups
Currently ADRO comprises five main multidisciplinary research groups, which work together to carry out complementary research programmes that fit with the overall strategy of ADRO. Individually the groups are nationally leading, but in combination the ADRO research programme is believed to be internationally competitive.
- Technical radiotherapy
Group Head: Dr Andrew Jackson/Professor Pat Price - Outcome measures
Group Head: Dr Susan Davidson - Molecular imaging/radiobiology
Group Head: Dr Azeem Saleem/Professor Pat Price - Translational radiobiology
Group Head: Dr Catharine West - Experimental radiotherapy
Group Head: Professor Pat Price
Partnership with the Wolfson Molecular Imaging Centre
There are considerable synergies between the research programmes of ADRO and the Wolfson Molecular Imaging Centre (WMIC), with co-supervision of students and collaborative research projects. This partnership provides substantial added-value to the research programmes of both, allowing ADRO access to state-of-the-art PET biomarker imaging in relation to radiotherapy and radiobiology, while affording the WMIC the opportunity to broaden the clinical application of molecular imaging research.
National radiotherapy strategies
Professor Price and ADRO also play a key role in development of national strategies for radiotherapy and related radiobiology research. Professor Price was invited by the National Cancer Research Institute (NCRI) to lead development of the new UK Academic Clinical Oncology and Radiobiology Research Network (ACORRN).
The University of Manchester is not responsible for the content of external internet sites.